Eli Lilly (LLY) PT Raised to $1,327 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,373.70 --0%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 31 | New: 3
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 31 | New: 3
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $1,327.00 (from $1,313.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,625 at UBS
- GoDaddy Inc (GDDY) PT Raised to $112 at UBS
- Eli Lilly (LLY) PT Raised to $1,650 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
